Akebia Therapeutics (AKBA) Return on Assets [ROA] (2014 - 2026)
Akebia Therapeutics (AKBA) posted Return on Assets [ROA] of -8.33% for Q2 2026, up 2.80 percentage points from -11.13% a year earlier but down 2.78 percentage points from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Akebia Therapeutics' Return on Assets [ROA] came in at -1.79%, up 28.23 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a five-year change of +52.59 percentage points (FY2020 to FY2025).
- In prior years, Akebia Therapeutics' Return on Assets [ROA] was -30.02% in FY2024 (-12.65 pp), -17.37% in FY2023 (+3.91 pp), -21.28% in FY2022 (+26.78 pp) and -48.07% in FY2021 (+6.32 pp).
- Quarterly Return on Assets [ROA] has run from a low of -48.39% in Q1 2022 to a high of -1.44% in Q4 2025 over five years.
- On a year-over-year basis, Return on Assets [ROA] has increased in each of the last six quarters, with an average year-over-year change of +7.76 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2023, with a gain of 33.29 percentage points; the weakest was Q4 2024, with a drop of 10.66 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -5.55% (Q1 2026), -1.44% (Q4 2025) and -4.48% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn | -12.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -12.88% |
| Jun 30, 2026 | -8.33% |
| Mar 31, 2026 | -5.55% |
| Dec 31, 2025 | -1.44% |
| Sep 30, 2025 | -4.48% |
| Jun 30, 2025 | -11.13% |
| Mar 31, 2025 | -17.07% |
| Dec 31, 2024 | -32.45% |
| Sep 30, 2024 | -21.52% |
| Jun 30, 2024 | -18.15% |
| Mar 31, 2024 | -18.42% |
| Dec 31, 2023 | -21.78% |
| Sep 30, 2023 | -23.98% |
| Jun 30, 2023 | -36.74% |
| Mar 31, 2023 | -18.08% |
| Dec 31, 2022 | -23.28% |
| Sep 30, 2022 | -32.22% |
| Jun 30, 2022 | -30.30% |
| Mar 31, 2022 | -51.32% |
| Dec 31, 2021 | -49.85% |
API Access
Akebia Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();